| INSILICO MEDICINE |
| China |
| Gesundheit |
| KYG4790P1037 / A41XT7 |
| O15 (Frankfurt) |
| FRA:O15, ETR:O15, O15:GR |
| - |
| https://insilico.com/ |
|
InSilico Medicine Cayman TopCo is an artificial intelligence-based biotechnology company focused on drug discovery and development. It leverages generative AI through its Pharma.AI platform, an end-to-end software and automation solution that enhance..
>Volltext.. |
| 2770.2 Mio. EUR |
| 2394.07 Mio. EUR |
| 49.34 Mio. EUR |
| -48.44 Mio. EUR |
| -309.19 Mio. EUR |
| - |
| 5.22 Mio. EUR |
| 344.5 Mio. EUR |
| -62.55 Mio. EUR |
| 13.2 |
| -42.45% |
| -1719.55% |
| - |
| - |
| - |
| - |
| INSILICO |
| 12.07.26 |
|